Orla Hardiman, M.D. - Publications

Affiliations: 
Academic Unit of Neurology Trinity College Dublin, the University of Dublin 

230 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Burke T, Wilson O'Raghallaigh J, Maguire S, Galvin M, Heverin M, Hardiman O, Pender N. Group interventions for amyotrophic lateral sclerosis caregivers in Ireland: a randomised controlled trial protocol. Bmj Open. 9: e030684. PMID 31542756 DOI: 10.1136/bmjopen-2019-030684  0.48
2019 Dukic S, McMackin R, Buxo T, Fasano A, Chipika R, Pinto-Grau M, Costello E, Schuster C, Hammond M, Heverin M, Coffey A, Broderick M, Iyer PM, Mohr K, Gavin B, ... ... Hardiman O, et al. Patterned functional network disruption in amyotrophic lateral sclerosis. Human Brain Mapping. PMID 31348605 DOI: 10.1002/hbm.24740  0.48
2019 Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, McLaughlin RL, Pender N, Hardiman O, Bede P. The clinical and radiological profile of primary lateral sclerosis: a population-based study. Journal of Neurology. PMID 31325016 DOI: 10.1007/s00415-019-09473-z  0.48
2019 McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O. Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30760643 DOI: 10.1136/jnnp-2018-319581  0.48
2019 McMackin R, Bede P, Pender N, Hardiman O, Nasseroleslami B. Neurophysiological markers of network dysfunction in neurodegenerative diseases. Neuroimage. Clinical. 22: 101706. PMID 30738372 DOI: 10.1016/j.nicl.2019.101706  0.48
2019 McMackin R, Dukic S, Broderick M, Iyer PM, Pinto-Grau M, Mohr K, Chipika R, Coffey A, Buxo T, Schuster C, Gavin B, Heverin M, Bede P, Pender N, Lalor EC, ... ... Hardiman O, et al. Dysfunction of attention switching networks in amyotrophic lateral sclerosis. Neuroimage. Clinical. 22: 101707. PMID 30735860 DOI: 10.1016/j.nicl.2019.101707  0.48
2019 Rogers M, Boland B, Clarke S, Craven A, Fassbender C, Gill M, Hardiman O, Henshall DC, Lynch T, Mitchell K, Pender N, Rogan C, Roche RA. Building a Supportive Framework for Brain Research in Ireland: Inaugural Position Paper of The Irish Brain Council. The European Journal of Neuroscience. PMID 30673123 DOI: 10.1111/ejn.14351  0.48
2018 Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, ... ... Hardiman O, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. PMID 30209236 DOI: 10.1212/WNL.0000000000006317  0.48
2018 Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A, Pender N, McLaughlin R, Hardiman O. Determining the incidence of familiality in ALS: A study of temporal trends in Ireland from 1994 to 2016. Neurology. Genetics. 4: e239. PMID 29845113 DOI: 10.1212/NXG.0000000000000239  0.48
2018 Pinto-Grau M, Hardiman O, Pender N. The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives. Neuropsychology Review. PMID 29705950 DOI: 10.1007/s11065-018-9375-7  0.48
2018 Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging and Behavior. PMID 29423814 DOI: 10.1007/s11682-018-9837-9  0.48
2018 Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K, Staines A, Galvin M, Pender N. Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads. Journal of Neurology. PMID 29396678 DOI: 10.1007/s00415-018-8770-6  0.48
2018 Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O. Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis. Bmj Open. 8: e018721. PMID 29374665 DOI: 10.1136/bmjopen-2017-018721  0.48
2017 Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, Costello E, Pinto-Grau M, Vajda A, Heverin M, Pender N, Al-Chalabi A, Hardiman O, Abrahams S. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 29214872 DOI: 10.1080/21678421.2017.1407794  0.48
2017 Nasseroleslami B, Dukic S, Broderick M, Mohr K, Schuster C, Gavin B, McLaughlin R, Heverin M, Vajda A, Iyer PM, Pender N, Bede P, Lalor EC, Hardiman O. Characteristic Increases in EEG Connectivity Correlate With Changes of Structural MRI in Amyotrophic Lateral Sclerosis. Cerebral Cortex (New York, N.Y. : 1991). 1-15. PMID 29136131 DOI: 10.1093/cercor/bhx301  0.48
2017 Dukic S, Iyer PM, Mohr K, Hardiman O, Lalor EC, Nasseroleslami B. Estimation of coherence using the median is robust against EEG artefacts. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2017: 3949-3952. PMID 29060761 DOI: 10.1109/EMBC.2017.8037720  0.48
2017 O'Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, Byrne S, Pinto-Grau M, Elamin M, Pender N, Hardiman O. Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 29049464 DOI: 10.1001/jamaneurol.2017.2699  0.48
2017 Iyer PM, Mohr K, Broderick M, Gavin B, Burke T, Bede P, Pinto-Grau M, Pender NP, McLaughlin R, Vajda A, Heverin M, Lalor EC, Hardiman O, Nasseroleslami B. Mismatch Negativity as an Indicator of Cognitive Sub-Domain Dysfunction in Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 8: 395. PMID 28861032 DOI: 10.3389/fneur.2017.00395  0.48
2017 Bede P, Iyer PM, Finegan E, Omer T, Hardiman O. Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns. Neuroimage. Clinical. 15: 653-658. PMID 28664036 DOI: 10.1016/j.nicl.2017.06.010  0.48
2017 Pinto-Grau M, Costello E, O'Connor S, Elamin M, Burke T, Heverin M, Pender N, Hardiman O. Assessing behavioural changes in ALS: cross-validation of ALS-specific measures. Journal of Neurology. PMID 28600595 DOI: 10.1007/s00415-017-8536-6  0.48
2017 Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, Pender N, Hardiman O, Bede P. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-13. PMID 28562080 DOI: 10.1080/21678421.2017.1332077  0.48
2017 Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, Hardiman O. A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Annals of Clinical and Translational Neurology. 4: 305-317. PMID 28491898 DOI: 10.1002/acn3.407  0.48
2017 Burke T, Galvin M, Pinto-Grau M, Lonergan K, Madden C, Mays I, Carney S, Hardiman O, Pender N. Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival. Journal of Neurology. PMID 28280986 DOI: 10.1007/s00415-017-8448-5  0.48
2017 Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N. Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 28084080 DOI: 10.1080/21678421.2016.1272615  0.48
2016 Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 27894201 DOI: 10.1080/21678421.2016.1249887  0.48
2016 Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O. Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27894191 DOI: 10.1080/21678421.2016.1248976  0.48
2016 Rooney J, Burke T, Vajda A, Heverin M, Hardiman O. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27888187 DOI: 10.1136/jnnp-2016-314661  0.48
2016 Rooney J, Fogh I, Westeneng HJ, Vajda A, McLaughlin R, Heverin M, Jones A, van Eijk R, Calvo A, Mazzini L, Shaw C, Morrison K, Shaw PJ, Robberecht W, Van Damme P, ... ... Hardiman O, et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27663272 DOI: 10.1136/jnnp-2016-314093  0.48
2016 Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N. Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study. Plos One. 11: e0160850. PMID 27556398 DOI: 10.1371/journal.pone.0160850  0.48
2016 Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P, Shatunov A, Sproviero W, Smith BN, van Es MA, Topp SD, ... ... Hardiman O, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics. PMID 27455347 DOI: 10.1038/ng.3626  0.48
2016 Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, Jones A, Sproviero W, Chiò A, McLaughlin RL, Sorarù G, ... ... Hardiman O, et al. Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 27244217 DOI: 10.1001/jamaneurol.2016.1114  0.48
2016 Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N. Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27152765 DOI: 10.1080/21678421.2016.1177088  0.48
2016 Rooney J, Heverin M, Vajda A, Burke T, Galvin M, Tobin K, Elamin M, Staines A, Hardiman O. Survival analysis of geospatial factors in the Irish ALS cohort. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27145090 DOI: 10.1080/21678421.2016.1179326  0.48
2016 Bede P, Iyer PM, Schuster C, Elamin M, Mclaughlin RL, Kenna K, Hardiman O. The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-10. PMID 27087114 DOI: 10.3109/21678421.2016.1173702  0.48
2016 Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, Zhang KY, Farrawell N, Vance C, Hu X, Chesi A, Leblond CS, Lee A, Rayner SL, Sundaramoorthy V, ... ... Hardiman O, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature Communications. 7: 11253. PMID 27080313 DOI: 10.1038/ncomms11253  0.48
2016 Foley G, Timonen V, Hardiman O. "I hate being a burden": The patient perspective on carer burden in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-7. PMID 26857752 DOI: 10.3109/21678421.2016.1143512  0.48
2016 Rooney J, Vajda A, Heverin M, Crampsie A, Tobin K, McLaughlin R, Staines A, Hardiman O. No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland. Environmental Research. 147: 102-107. PMID 26855128 DOI: 10.1016/j.envres.2016.01.038  0.48
2016 Martiniano R, Caffell A, Holst M, Hunter-Mann K, Montgomery J, Müldner G, McLaughlin RL, Teasdale MD, van Rheenen W, Veldink JH, van den Berg LH, Hardiman O, Carroll M, Roskams S, Oxley J, et al. Genomic signals of migration and continuity in Britain before the Anglo-Saxons. Nature Communications. 7: 10326. PMID 26783717 DOI: 10.1038/ncomms10326  0.48
2015 Burke T, Elamin M, Galvin M, Gallagher L, Hardiman O, Pender N. Erratum to: Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. Journal of Neurology. PMID 26566911 DOI: 10.1007/s00415-015-7941-y  0.48
2015 Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J. A revision of the El Escorial criteria - 2015. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 16: 291-2. PMID 26121170 DOI: 10.3109/21678421.2015.1049183  0.48
2015 Iyer PM, Egan C, Pinto-Grau M, Burke T, Elamin M, Nasseroleslami B, Pender N, Lalor EC, Hardiman O. Functional Connectivity Changes in Resting-State EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis. Plos One. 10: e0128682. PMID 26091258 DOI: 10.1371/journal.pone.0128682  0.48
2015 McLaughlin RL, Vajda A, Hardiman O. Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers. Jama Neurology. PMID 26029874 DOI: 10.1001/jamaneurol.2014.4049  0.48
2015 Burke T, Elamin M, Galvin M, Hardiman O, Pender N. Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. Journal of Neurology. 262: 1526-32. PMID 25904206 DOI: 10.1007/s00415-015-7746-z  0.48
2015 Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. Journal of Neurology. 262: 1447-54. PMID 25860344 DOI: 10.1007/s00415-015-7731-6  0.48
2015 Rooney J, Vajda A, Heverin M, Elamin M, Crampsie A, McLaughlin R, Staines A, Hardiman O. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland Neurology. 84: 1537-1544. PMID 25770197 DOI: 10.1212/WNL.0000000000001477  0.48
2015 Connolly S, Galvin M, Hardiman O. End-of-life management in patients with amyotrophic lateral sclerosis The Lancet Neurology. 14: 435-442. PMID 25728958 DOI: 10.1016/S1474-4422(14)70221-2  0.48
2015 Schuster C, Elamin M, Hardiman O, Bede P. Presymptomatic and longitudinal neuroimaging in neurodegeneration-from snapshots to motion picture: a systematic review. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25632156 DOI: 10.1136/jnnp-2014-309888  0.48
2015 Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, Hardiman O. A multidisciplinary clinic approach improves survival in ALS:A comparative study of ALS in Ireland and Northern Ireland Journal of Neurology, Neurosurgery and Psychiatry. 86: 496-501. PMID 25550416 DOI: 10.1136/jnnp-2014-309601  0.48
2015 Bonini NM, Hardiman O. Ataxin-2 expands insight into the ALS clinical spectrum. Neurology. 84: 224-5. PMID 25527266 DOI: 10.1212/WNL.0000000000001167  0.48
2015 Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, Nakano I, Shaw P, Shefner J, van den Berg LH, Ludolph A. The El Escorial criteria: strengths and weaknesses. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 16: 1-7. PMID 25482030 DOI: 10.3109/21678421.2014.964258  0.48
2015 Lefter S, Hardiman O, McLaughlin RL, Murphy SM, Farrell M, Ryan AM. A novel MYH7 Leu1453pro mutation resulting in Laing distal myopathy in an Irish family. Neuromuscular Disorders : Nmd. 25: 155-60. PMID 25447691 DOI: 10.1016/j.nmd.2014.09.007  0.48
2015 McLaughlin RL, Kenna KP, Vajda A, Bede P, Elamin M, Cronin S, Donaghy CG, Bradley DG, Hardiman O. Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis. Neurobiology of Aging. 36: 1221.e7-13. PMID 25442119 DOI: 10.1016/j.neurobiolaging.2014.08.030  0.48
2015 Küffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, Li G, Fang L, Mackey L, Hardiman O, Cudkowicz M, Sherman A, Ertaylan G, Grosse-Wentrup M, Hothorn T, et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nature Biotechnology. 33: 51-7. PMID 25362243 DOI: 10.1038/nbt.3051  0.48
2015 Kelly JA, Boyle NT, Cole N, Slator GR, Colivicchi MA, Stefanini C, Gobbo OL, Scalabrino GA, Ryan SM, Elamin M, Walsh C, Vajda A, Goggin MM, Campbell M, Mash DC, ... ... Hardiman O, et al. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology. 89: 193-203. PMID 25281210 DOI: 10.1016/j.neuropharm.2014.09.024  0.48
2015 Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Fagan A, Bradley DG, Hardiman O. Patterns of cerebral and cerebellar white matter degeneration in ALS. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 468-70. PMID 25053771 DOI: 10.1136/jnnp-2014-308172  0.48
2015 Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, et al. ALSUntangled No. 29: MitoQ Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16: 427-429. DOI: 10.3109/21678421.2015.1050897  0.48
2015 Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, et al. ALSUntangled: Introducing the table of evidence Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16: 142-145. DOI: 10.3109/21678421.2014.987476  0.48
2015 Connolly S, Heslin C, Mays I, Corr B, Normand C, Hardiman O. Health and social care costs of managing amyotrophic lateral sclerosis (ALS): An Irish perspective Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16: 58-62. DOI: 10.3109/21678421.2014.957322  0.48
2015 Galvin M, Madden C, Maguire S, Heverin M, Vajda A, Staines A, Hardiman O. Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: An exploratory study Bmc Health Services Research. DOI: 10.1186/s12913-015-1229-x  0.48
2015 Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Fagan A, Bradley DG, Hardiman O. Patterns of cerebral and cerebellar white matter degeneration in ALS Journal of Neurology, Neurosurgery and Psychiatry. 86: 468-470. DOI: 10.1136/jnnp-2014-308172  0.48
2015 Burke T, Wynne B, O'Brien C, Elamin M, Bede P, Hardiman O, Pender N. Retrospective investigations of practice effects on repeated neuropsychological measures of executive functioning Irish Journal of Psychology. DOI: 10.1080/03033910.2015.1044554  0.48
2015 Burke T, Healy D, Casey P, Hardiman O, Pender N. Atypical social cognitive processing in premotor Huntington’s disease: a single case study Irish Journal of Psychological Medicine. DOI: 10.1017/ipm.2015.48  0.48
2015 McLaughlin RL, Kenna KP, Vajda A, Heverin M, Byrne S, Donaghy CG, Cronin S, Bradley DG, Hardiman O. Homozygosity mapping in an Irish ALS case-control cohort describes local demographic phenomena and points towards potential recessive risk loci Genomics. 105: 237-241. DOI: 10.1016/j.ygeno.2015.01.002  0.48
2015 McLaughlin RL, Kenna KP, Vajda A, Bede P, Elamin M, Cronin S, Donaghy CG, Bradley DG, Hardiman O. A second-generation Irish genome-wide association study for amyotrophic lateral sclerosis Neurobiology of Aging. 36: 1221.e7-1221.e13. DOI: 10.1016/j.neurobiolaging.2014.08.030  0.48
2015 Rooney JPK, Tobin K, Crampsie A, Vajda A, Heverin M, McLaughlin R, Staines A, Hardiman O. Social deprivation and population density are not associated with small area risk of amyotrophic lateral sclerosis Environmental Research. 142: 141-147. DOI: 10.1016/j.envres.2015.06.024  0.48
2015 Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm Journal of Neurology. 262: 1447-1454. DOI: 10.1007/s00415-015-7731-6  0.48
2014 Lefter S, Hardiman O, Ryan AM. Methodology and design of a national epidemiological study on adult neuromuscular disease Neuroepidemiology. 43: 123-130. PMID 25376451 DOI: 10.1159/000367634  0.48
2014 Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, ... ... Hardiman O, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 84: 324-31. PMID 25374358 DOI: 10.1016/j.neuron.2014.09.027  0.48
2014 Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. The Lancet. Neurology. 13: 1108-13. PMID 25300936 DOI: 10.1016/S1474-4422(14)70219-4  0.48
2014 van Doormaal PT, Ticozzi N, Gellera C, Ratti A, Taroni F, Chiò A, Calvo A, Mora G, Restagno G, Traynor BJ, Birve A, Lemmens R, van Es MA, Saris CG, Blauw HM, ... ... Hardiman O, et al. Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study. Neurobiology of Aging. 35: 2420.e13-4. PMID 24838185 DOI: 10.1016/j.neurobiolaging.2014.04.014  0.48
2014 Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M, Lunetta C, Marin B, Hardiman O, Rooney J, Stevic Z, Bandettini Di Poggio M, Filosto M, et al. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study Annals of Neurology. 75: 708-716. PMID 24706338 DOI: 10.1002/ana.24150  0.48
2014 Foley G, Timonen V, Hardiman O. Understanding psycho-social processes underpinning engagement with services in motor neurone disease: A qualitative study Palliative Medicine. 28: 318-325. PMID 24637571 DOI: 10.1177/0269216313512013  0.48
2014 Foley G, Timonen V, Hardiman O. Exerting control and adapting to loss in amyotrophic lateral sclerosis Social Science and Medicine. 101: 113-119. PMID 24560231 DOI: 10.1016/j.socscimed.2013.11.003  0.48
2014 Byrne S, Heverin M, Bede P, Elamin M, Hardiman O. Fecundity in ALS Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 204-206. PMID 24479554 DOI: 10.3109/21678421.2013.865237  0.48
2014 Fahey C, Byrne S, McLaughlin R, Kenna K, Shatunov A, Donohoe G, Gill M, Al-Chalabi A, Bradley DG, Hardiman O, Corvin AP, Morris DW. Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample. Neurobiology of Aging. 35: 1510.e1-5. PMID 24411481 DOI: 10.1016/j.neurobiolaging.2013.12.003  0.48
2014 Bede P, Elamin M, Byrne S, Hardiman O. Sexual dimorphism in ALS: Exploring gender-specific neuroimaging signatures Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 235-242. PMID 24344910 DOI: 10.3109/21678421.2013.865749  0.48
2014 Foley G, Timonen V, Hardiman O. Acceptance and decision making in amyotrophic lateral sclerosis from a life-course perspective Qualitative Health Research. 24: 67-77. PMID 24336481 DOI: 10.1177/1049732313516545  0.48
2014 Murray D, Hardiman O, Meldrum D. Assessment of subjective and motor fatigue in Polio survivors, attending a Postpolio clinic, comparison with healthy controls and an exploration of clinical correlates Physiotherapy Theory and Practice. 30: 229-235. PMID 24328931 DOI: 10.3109/09593985.2013.862890  0.48
2014 Bede P, Walsh R, Fagan AJ, Hardiman O. "Sand-watch" spinal cord: A case of inferior cervical spinal cord atrophy Journal of Neurology. 261: 235-237. PMID 24281771 DOI: 10.1007/s00415-013-7193-7  0.48
2014 Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, Corrado L, Sorarù G, Cereda C, Corti S, Gentilini D, Calini D, Castellotti B, Mazzini L, Querin G, ... ... Hardiman O, et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Human Molecular Genetics. 23: 2220-31. PMID 24256812 DOI: 10.1093/hmg/ddt587  0.48
2014 Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ, van Es M, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Human Molecular Genetics. 23: 1916-22. PMID 24234648 DOI: 10.1093/hmg/ddt574  0.48
2014 Byrne S, Heverin M, Elamin M, Walsh C, Hardiman O. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 148-150. PMID 24053774 DOI: 10.3109/21678421.2013.838586  0.48
2014 McLaughlin RL, Kenna KP, Vajda A, Byrne S, Bradley DG, Hardiman O. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in ireland Neurobiology of Aging. 35: 267.e9-267.e11. PMID 23973441 DOI: 10.1016/j.neurobiolaging.2013.07.023  0.48
2014 Bedlack R, Quinn C, Karam C, Sherman A, Ostrow L, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, et al. ALSUntangled no. 26: Lunasin Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 622-626. DOI: 10.3109/21678421.2014.959297  0.48
2014 Bede P, Hardiman O. Subcortical gray matter structures: A future biomarker for amyotrophic lateral sclerosis? Future Neurology. 9: 109-111. DOI: 10.2217/fnl.14.3  0.48
2014 Rooney J, Heverin M, Vajda A, Crampsie A, Tobin K, Byrne S, Staines A, Hardiman O. An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995 - July 2013) Plos One. 9. DOI: 10.1371/journal.pone.0096556  0.48
2014 Bede P, Hardiman O. Lessons of ALS imaging: Pitfalls and future directions - A critical review Neuroimage: Clinical. 4: 436-443. DOI: 10.1016/j.nicl.2014.02.011  0.48
2014 Lefter S, Hardiman O, Costigan D, Lynch B, McConville J, Hand CK, Ryan AM. Andersen-tawil syndrome with early fixed myopathy Journal of Clinical Neuromuscular Disease. 16: 79-82.  0.48
2013 Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Pender N, Bradley DG, Hardiman O. Basal ganglia involvement in amyotrophic lateral sclerosis Neurology. 81: 2107-2115. PMID 24212388 DOI: 10.1212/01.wnl.0000437313.80913.2c  0.48
2013 Al-Chalabi A, Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time Nature Reviews Neurology. 9: 617-628. PMID 24126629 DOI: 10.1038/nrneurol.2013.203  0.48
2013 Rooney J, Byrne S, Heverin M, Corr B, Elamin M, Staines A, Goldacre B, Hardiman O. Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995-2010 Plos One. 8. PMID 24098664 DOI: 10.1371/journal.pone.0074733  0.48
2013 Cudkowicz ME, van den Berg LH, Shefner JM, Mitsumoto H, Mora JS, Ludolph A, Hardiman O, Bozik ME, Ingersoll EW, Archibald D, Meyers AL, Dong Y, Farwell WR, Kerr DA. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. The Lancet. Neurology. 12: 1059-67. PMID 24067398 DOI: 10.1016/S1474-4422(13)70221-7  0.48
2013 Byrne S, Jordan I, Elamin M, Hardiman O. Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14: 604-607. PMID 23895536 DOI: 10.3109/21678421.2013.809122  0.48
2013 Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, Cormican P, Morris DW, Donaghy CG, Bradley DG, Hardiman O. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. Journal of Medical Genetics. 50: 776-83. PMID 23881933 DOI: 10.1136/jmedgenet-2013-101795  0.48
2013 Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, MacLaughlin R, Walsh C, Al Chalabi A, Hardiman O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Annals of Neurology. 74: 699-708. PMID 23836460 DOI: 10.1002/ana.23969  0.48
2013 Bede P, Bokde ALW, Byrne S, Elamin M, McLaughlin RL, Kenna K, Fagan AJ, Pender N, Bradley DG, Hardiman O. Multiparametric MRI study of ALS stratified for the C9orf72 genotype Neurology. 81: 361-369. PMID 23771489 DOI: 10.1212/WNL.0b013e31829c5eee  0.48
2013 Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chío A, Garruto R, Hardiman O, Kamel F, Kasarskis E, McKee A, Nakano I, Nelson LM, Eisen A. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 33-43. PMID 23678878 DOI: 10.3109/21678421.2013.778565  0.48
2013 Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, et al. ALS Untangled No. 20: the Deanna protocol. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 319-23. PMID 23638638 DOI: 10.3109/21678421.2013.788405  0.48
2013 Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O'Brien C, Phukan J, Lynch C, Pender N, Hardiman O. Cognitive changes predict functional decline in ALS: A population-based longitudinal study Neurology. 80: 1590-1597. PMID 23553481 DOI: 10.1212/WNL.0b013e31828f18ac  0.48
2013 Kenna KP, Mclaughlin RL, Hardiman O, Bradley DG. Using Reference Databases of Genetic Variation to Evaluate the Potential Pathogenicity of Candidate Disease Variants Human Mutation. 34: 836-841. PMID 23447461 DOI: 10.1002/humu.22303  0.48
2013 Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, et al. Controversies and priorities in amyotrophic lateral sclerosis. The Lancet. Neurology. 12: 310-22. PMID 23415570 DOI: 10.1016/S1474-4422(13)70036-X  0.48
2013 Byrne S, Pradhan F, Dhubhghaill SN, Treacy M, Cassidy L, Hardiman O. Blink rate in ALS Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14: 291-293. PMID 23151260 DOI: 10.3109/21678421.2012.729217  0.48
2013 Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 766-73. PMID 23085933 DOI: 10.1136/jnnp-2012-302674  0.48
2013 van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, Shatunov A, Czell D, van Es MA, van Vught PW, van Damme P, Smith BN, Waibel S, Schelhaas HJ, van der Kooi AJ, ... ... Hardiman O, et al. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiology of Aging. 34: 1517.e5-7. PMID 23063643 DOI: 10.1016/j.neurobiolaging.2012.07.020  0.48
2013 Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, Maclaughlin R, Walsh C, Al Chalabi A, Hardiman O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis Annals of Neurology. 74: 699-708. DOI: 10.1002/ana.23969  0.48
2012 Murray D, Meldrum D, Moloney R, Campion A, Horgan F, Hardiman O. The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in polio survivors: Protocol for a randomised controlled trial Bmc Neurology. 12. PMID 23234560 DOI: 10.1186/1471-2377-12-157  0.48
2012 Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, ... ... Hardiman O, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nature Medicine. 18: 1418-22. PMID 22922411 DOI: 10.1038/nm.2901  0.48
2012 Bedlack R, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, et al. ALS untangled no. 17: "When ALS Is Lyme" Amyotrophic Lateral Sclerosis. 13: 487-491. PMID 22873562 DOI: 10.3109/17482968.2012.717796  0.48
2012 Elamin M, Pender N, Hardiman O, Abrahams S. Social cognition in neurodegenerative disorders: A systematic review Journal of Neurology, Neurosurgery and Psychiatry. 83: 1071-1079. PMID 22869923 DOI: 10.1136/jnnp-2012-302817  0.48
2012 Hardiman O, Figlewicz DA. The expansions of ALS. Neurology. 79: 842-3. PMID 22843260 DOI: 10.1212/WNL.0b013e3182662031  0.48
2012 Bedlack R, Hardiman O, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, et al. ALSUntangled No. 16: Cannabis Amyotrophic Lateral Sclerosis. 13: 400-404. PMID 22632446 DOI: 10.3109/17482968.2012.687264  0.48
2012 Pupillo E, Messina P, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M, Lunetta C, Micheli A, Millul A, Vitelli E, Beghi E, Bissolati M, Formaglio F, Gerardi F, ... ... Hardiman O, et al. Trauma and amyotrophic lateral sclerosis: A case-control study from a population-based registry European Journal of Neurology. 19: 1509-1517. PMID 22537412 DOI: 10.1111/j.1468-1331.2012.03723.x  0.48
2012 Diekstra FP, Saris CG, van Rheenen W, Franke L, Jansen RC, van Es MA, van Vught PW, Blauw HM, Groen EJ, Horvath S, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Robberecht W, ... ... Hardiman O, et al. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. Plos One. 7: e35333. PMID 22509407 DOI: 10.1371/journal.pone.0035333  0.48
2012 Byrne S, Elamin M, Bede P, Hardiman O. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases Journal of Neurology, Neurosurgery and Psychiatry. 83: 365-367. PMID 22399794 DOI: 10.1136/jnnp-2011-301530  0.48
2012 Bede P, Bokde ALW, Byrne S, Elamin M, Fagan AJ, Hardiman O. Spinal cord markers in ALS: Diagnostic and biomarker considerations Amyotrophic Lateral Sclerosis. 13: 407-415. PMID 22329869 DOI: 10.3109/17482968.2011.649760  0.48
2012 Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, ... ... Hardiman O, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study The Lancet Neurology. 11: 232-240. PMID 22305801 DOI: 10.1016/S1474-4422(12)70014-5  0.48
2012 Hardiman O. Multidisciplinary care in ALS: Expanding the team Amyotrophic Lateral Sclerosis. 13: 165. PMID 22292839 DOI: 10.3109/17482968.2012.657006  0.48
2012 Foley G, Timonen V, Hardiman O. Experience of Services as a Key Outcome in Amyotrophic Lateral Sclerosis (ALS) Care: The Case for a Better Understanding of Patient Experiences American Journal of Hospice and Palliative Medicine. 29: 362-367. PMID 21998444 DOI: 10.1177/1049909111423774  0.48
2012 Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 360-75. PMID 21914052 DOI: 10.1111/j.1468-1331.2011.03501.x  0.48
2012 Foley G, Timonen V, Hardiman O. Patients' perceptions of services and preferences for care in amyotrophic lateral sclerosis: A review Amyotrophic Lateral Sclerosis. 13: 11-24. PMID 21879834 DOI: 10.3109/17482968.2011.607500  0.48
2012 Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study Journal of Neurology, Neurosurgery and Psychiatry. 83: 102-108. PMID 21836033 DOI: 10.1136/jnnp-2011-300188  0.48
2012 Bedlack R, Hardiman O, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, et al. ALS untangled 15: Coconut oil Amyotrophic Lateral Sclerosis. 13: 328-330. DOI: 10.3109/17482968.2012.671629  0.48
2011 Hardiman O, Van Den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis Nature Reviews Neurology. 7: 639-649. PMID 21989247 DOI: 10.1038/nrneurol.2011.153  0.48
2011 Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, Cotter DR, Murphy KC. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 199: 508-9. PMID 21984802 DOI: 10.1192/bjp.bp.111.092197  0.48
2011 Beghi E, Pupillo E, Messina P, Giussani G, Chiò A, Zoccolella S, Moglia C, Corbo M, Logroscino G, Al-Chalabi A, Hardiman O, Ludolph A, Mitchell D, Preux PM, Swingler R, et al. Coffee and amyotrophic lateral sclerosis: A possible preventive role American Journal of Epidemiology. 174: 1002-1008. PMID 21946385 DOI: 10.1093/aje/kwr229  0.48
2011 Geser F, Prvulovic D, O'Dwyer L, Hardiman O, Bede P, Bokde AL, Trojanowski JQ, Hampel H. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Progress in Neurobiology. 95: 649-62. PMID 21911035 DOI: 10.1016/j.pneurobio.2011.08.011  0.48
2011 Hardiman O. Amyotrophic lateral sclerosis and vascular risk: A metabolic conundrum Journal of Neurology, Neurosurgery and Psychiatry. 82: 591. PMID 21551170 DOI: 10.1136/jnnp.2011.241539  0.48
2011 Bede P, Bokde ALW, Byrne SC, Elamin M, Walsh RJ, Hardiman O. Waterskier's Hirayama syndrome Journal of Neurology. 258: 2078-2079. PMID 21503827 DOI: 10.1007/s00415-011-6046-5  0.48
2011 Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, Hardiman O. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia Neurology. 76: 1263-1269. PMID 21464431 DOI: 10.1212/WNL.0b013e318214359f  0.48
2011 Bede P, Oliver D, Stodart J, Van Den Berg L, Simmons Z, Brannagáin DO, Borasio GD, Hardiman O. Palliative care in amyotrophic lateral sclerosis: A review of current international guidelines and initiatives Journal of Neurology, Neurosurgery and Psychiatry. 82: 413-418. PMID 21297150 DOI: 10.1136/jnnp.2010.232637  0.48
2011 Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 377: 942-55. PMID 21296405 DOI: 10.1016/S0140-6736(10)61156-7  0.48
2011 Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, Hardiman O. Proposed criteria for familial amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis. 12: 157-159. PMID 21208036 DOI: 10.3109/17482968.2010.545420  0.48
2011 Hardiman O. Management of respiratory symptoms in ALS Journal of Neurology. 258: 359-365. PMID 21082322 DOI: 10.1007/s00415-010-5830-y  0.48
2011 Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis Journal of Neurology, Neurosurgery and Psychiatry. 82: 623-627. PMID 21047878 DOI: 10.1136/jnnp.2010.224501  0.48
2011 Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 1-10. PMID 20698807 DOI: 10.3109/17482968.2010.502940  0.48
2010 McLaughlin RL, Phukan J, McCormack W, Lynch DS, Greenway M, Cronin S, Saunders J, Slowik A, Tomik B, Andersen PM, Bradley DG, Jakeman P, Hardiman O. Angiogenin levels and ANG genotypes: Dysregulation in amyotrophic lateral sclerosis Plos One. 5. PMID 21085671 DOI: 10.1371/journal.pone.0015402  0.48
2010 Tong P, Prendergast JG, Lohan AJ, Farrington SM, Cronin S, Friel N, Bradley DG, Hardiman O, Evans A, Wilson JF, Loftus B. Sequencing and analysis of an Irish human genome. Genome Biology. 11: R91. PMID 20822512 DOI: 10.1186/gb-2010-11-9-r91  0.48
2010 Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den Berg LH, Robberecht W, Van Damme P, Hardiman O, Farmer AE, Lewis CM, et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. The Lancet. Neurology. 9: 986-94. PMID 20801717 DOI: 10.1016/S1474-4422(10)70197-6  0.48
2010 Blauw HM, Al-Chalabi A, Andersen PM, van Vught PWJ, Diekstra FP, van Es MA, Saris CGJ, Groen EJN, van Rheenen W, Koppers M, Slot Rvt, Strengman E, Estrada K, Rivadeneira F, Hofman A, ... ... Hardiman O, et al. A large genome scan for rare CNVs in amyotrophic lateral sclerosis Human Molecular Genetics. 19: 4091-4099. PMID 20685689 DOI: 10.1093/hmg/ddq323  0.48
2010 Donaghy C, Clarke J, Patterson C, Kee F, Hardiman O, Patterson V. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 374-8. PMID 20550486 DOI: 10.3109/17482960903329569  0.48
2010 Byrne S, Hardiman O. Willful modulation of brain activity in disorders of consciousness. The New England Journal of Medicine. 362: 1936; author reply 1. PMID 20484402  0.48
2010 Byrne S, Hardiman O. Familial aggregation in amyotrophic lateral sclerosis Annals of Neurology. 67: 554. PMID 20437599 DOI: 10.1002/ana.21883  0.48
2010 Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, Swingler R, Traynor BJ. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 289-92. PMID 20433412 DOI: 10.3109/17482960903384283  0.48
2010 O'Doherty LJ, Hickey A, Hardiman O. Measuring life quality, physical function and psychological well-being in neurological illness Amyotrophic Lateral Sclerosis. 11: 461-468. PMID 20192883 DOI: 10.3109/17482960903552488  0.48
2010 Yeo L, Lynch C, Hardiman O. Validating population-based registers for ALS: How accurate is death certification? Journal of Neurology. 257: 1235-1239. PMID 20151145 DOI: 10.1007/s00415-010-5494-7  0.48
2010 Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V, McGivern RC, Gibson JM. Slow saccades in bulbar-onset motor neurone disease Journal of Neurology. 257: 1134-1140. PMID 20146069 DOI: 10.1007/s00415-010-5478-7  0.48
2010 Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 385-90. PMID 19710046 DOI: 10.1136/jnnp.2009.183525  0.48
2010 Phukan J, Ali E, Pender NP, Molloy F, Hennessy M, Walsh RJ, Hardiman O. Huntington's disease presenting as amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 405-7. PMID 19530012 DOI: 10.1080/17482960903055958  0.48
2010 Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M. Management of Amyotrophic Lateral Sclerosis European Handbook of Neurological Management: Second Edition. 1: 283-310. DOI: 10.1002/9781444328394.ch17  0.48
2009 Ryan AM, Ryan J, Wan-Ahmed M, Hardiman O, Farrell MA, McNamara B, Sweeney BJ. Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. Bmj Case Reports. 2009. PMID 21686700 DOI: 10.1136/bcr.08.2008.0650  0.48
2009 Van Es MA, Van Vught PW, Veldink JH, Andersen PM, Birve A, Lemmens R, Cronin S, Van Der Kooi AJ, De Visser M, Schelhaas HJ, Hardiman O, Ragoussis I, Lambrechts D, Robberecht W, Wokke JH, et al. Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 441-7. PMID 19922138 DOI: 10.3109/17482960802673042  0.48
2009 Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 310-23. PMID 19922118 DOI: 10.3109/17482960802566824  0.48
2009 Hardiman O. Ten years of the ALS journal. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 257. PMID 19922111 DOI: 10.3109/17482960903363287  0.48
2009 Mohammad AF, Khan KA, Galvin L, Hardiman O, O'Connell PG. High incidence of osteoporosis and fractures in an aging post-polio population. European Neurology. 62: 369-74. PMID 19797901 DOI: 10.1159/000242444  0.48
2009 Bedlack R, Hardiman O. ALSUntangled (ALSU): A scientific approach to off-label treatment options for people with ALS using tweets and twitters Amyotrophic Lateral Sclerosis. 10: 129-130. PMID 19455452 DOI: 10.1080/17482960903015986  0.48
2009 Armon C, Hardiman O. Computerized databases for ALS incidence calculations: Ready, steady, but don't go yet European Journal of Neurology. 16: 651-652. PMID 19453692 DOI: 10.1111/j.1468-1331.2009.02582.x  0.48
2009 O'Connor G, King M, Salomons G, Jakobs C, Hardiman O. A novel mutation as a cause of L-2-hydroxyglutaric aciduria Journal of Neurology. 256: 672-673. PMID 19444541 DOI: 10.1007/s00415-009-0107-z  0.48
2009 Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: A population-based mortality study Neurology. 72: 1640-1645. PMID 19433736 DOI: 10.1212/WNL.0b013e3181a55f7b  0.48
2009 Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM, Valdmanis PN, Meininger V, Melki J, Shaw CE, Rouleau GA, Fisher EM, Shaw PJ, Morrison KE, Pamphlett R, ... ... Hardiman O, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 73: 16-24. PMID 19321847 DOI: 10.1212/WNL.0b013e3181a18674  0.48
2009 Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V, McGivern RC, Gibson JM. Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction? Journal of Neurology. 256: 420-6. PMID 19306041 DOI: 10.1007/s00415-009-0109-x  0.48
2009 McEvoy BP, Montgomery GW, McRae AF, Ripatti S, Perola M, Spector TD, Cherkas L, Ahmadi KR, Boomsma D, Willemsen G, Hottenga JJ, Pedersen NL, Magnusson PK, Kyvik KO, Christensen K, ... ... Hardiman O, et al. Geographical structure and differential natural selection among North European populations. Genome Research. 19: 804-14. PMID 19265028 DOI: 10.1101/gr.083394.108  0.48
2009 Phukan J, Hardiman O. The management of amyotrophic lateral sclerosis Journal of Neurology. 256: 176-186. PMID 19224316 DOI: 10.1007/s00415-009-0142-9  0.48
2009 O'Sullivan EP, Behan LA, King TFJ, Hardiman O, Smith D. A case of stiff-person syndrome, type 1 diabetes, celiac disease and dermatitis herpetiformis Clinical Neurology and Neurosurgery. 111: 384-386. PMID 19150172 DOI: 10.1016/j.clineuro.2008.11.006  0.48
2009 Donaghy C, O'Toole O, Sheehan C, Kee F, Hardiman O, Patterson V. An all-Ireland epidemiological study of MND, 2004-2005 European Journal of Neurology. 16: 148-153. PMID 19087159 DOI: 10.1111/j.1468-1331.2008.02361.x  0.48
2009 Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O. Screening for replication of genome-wide SNP associations in sporadic ALS European Journal of Human Genetics. 17: 213-218. PMID 18987618 DOI: 10.1038/ejhg.2008.194  0.48
2009 Giovannoni G, Barbarash O, Casset-Semanaz F, King J, Metz L, Pardo G, Simsarian J, Sørensen PS, Stubinski B. Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 219-28. PMID 18755819 DOI: 10.1177/1352458508097299  0.48
2009 Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds Amyotrophic Lateral Sclerosis. 10: 95-98. PMID 18608094 DOI: 10.1080/17482960802209664  0.48
2008 Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG, Fenner B, Hardiman O, Prehn JHM. Control of motoneuron survival by angiogenin Journal of Neuroscience. 28: 14056-14061. PMID 19109488 DOI: 10.1523/JNEUROSCI.3399-08.2008  0.48
2008 Cronin S, Blauw HM, Veldink JH, Van Es MA, Ophoff RA, Bradley DG, van den Berg LH, Hardiman O. Analysis of genome-wide copy number variation in Irish and Dutch ALS populations Human Molecular Genetics. 17: 3392-3398. PMID 18689356 DOI: 10.1093/hmg/ddn233  0.48
2008 Cronin S, Greenway MJ, Andersen PM, Hardiman O. Screening of hypoxia-inducible genes in sporadic ALS Amyotrophic Lateral Sclerosis. 9: 299-305. PMID 18608101 DOI: 10.1080/17482960802160297  0.48
2008 Broom WJ, Greenway M, Sadri-Vakili G, Russ C, Auwarter KE, Glajch KE, Dupre N, Swingler RJ, Purcell S, Hayward C, Sapp PC, McKenna-Yasek D, Valdmanis PN, Bouchard JP, Meininger V, ... ... Hardiman O, et al. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 229-37. PMID 18608091 DOI: 10.1080/17482960802103107  0.48
2008 Meisler MH, Russ C, Montgomery KT, Greenway M, Ennis S, Hardiman O, Figlewicz DA, Quenneville NR, Conibear E, Brown RH. Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 141-8. PMID 18574757 DOI: 10.1080/17482960801934403  0.48
2008 Del Barco DG, Berlanga Acosta J, Penton Arias E, Hardiman O, Montero E. Boosting controlled autoimmunity: A new therapeutic target for CNS disorders Expert Review of Neurotherapeutics. 8: 819-825. PMID 18457538 DOI: 10.1586/14737175.8.5.819  0.48
2008 Donaghy C, Dick A, Hardiman O, Patterson V. Timeliness of diagnosis in Motor Neurone Disease: A population-based study Ulster Medical Journal. 77: 18-21. PMID 18269112  0.48
2008 Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, Swingler RJ, Beghi E. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 6-11. PMID 18079297 DOI: 10.1136/jnnp.2006.104828  0.48
2008 Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Human Molecular Genetics. 17: 768-74. PMID 18057069 DOI: 10.1093/hmg/ddm361  0.48
2008 Chiò A, Traynor BJ, Swingler R, Mitchell D, Hardiman O, Mora G, Beghi E, Logroscino G. Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthen the previous findings. Journal of the Neurological Sciences. 269: 187-8; author reply . PMID 17996254 DOI: 10.1016/j.jns.2007.10.005  0.48
2008 O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 30-2. PMID 17634215 DOI: 10.1136/jnnp.2007.117788  0.48
2008 Hardiman O. A new editor for the "black but not bleak" journal - ALS research is coming of age Amyotrophic Lateral Sclerosis. 9: 3. DOI: 10.1080/17482960801928777  0.48
2008 Kollewe K, Andersen PM, Borasio GD, Hardiman O, Leigh PN, Pradat PF, Silani V, Tomik B, Dengler R. Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points from the EALSC working group | Klinische leitlinien zur behandlung der amyotrophen lateralsklerose: Evidenzbasierte übersicht mit therapieempfehlungen der Arbeitsgruppe der EALSC und der EFNS Nervenheilkunde. 27: 302-316.  0.48
2007 Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ, Al-Chalabi A. The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Current Medicinal Chemistry. 14: 3185-200. PMID 18220753 DOI: 10.2174/092986707782793862  0.48
2007 Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurology. 6: 994-1003. PMID 17945153 DOI: 10.1016/S1474-4422(07)70265-X  0.48
2007 Logroscino G, Beghi E, Hardiman O, Chio A, Mitchell JD, Swingler RJ, Traynor B. Effect of referral bias on assessing survival in ALS [5] Neurology. 69: 939. PMID 17724304 DOI: 10.1212/01.wnl.0000281904.21495.cb  0.48
2007 Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H, Moore D, Pohlmann H, Sauer D, Silani V, Strong M, Swash M, Vernotica E, Cashman N, Eisen A, ... ... Hardiman O, et al. Phase II/III randomized trial of TCH346 in patients with ALS Neurology. 69: 776-784. PMID 17709710 DOI: 10.1212/01.wnl.0000269676.07319.09  0.48
2007 Cronin S, Greenway MJ, Prehn JHM, Hardiman O. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis Journal of Neurology, Neurosurgery and Psychiatry. 78: 984-986. PMID 17702780 DOI: 10.1136/jnnp.2006.112581  0.48
2007 Hosback S, Hardiman O, Nolan CM, Doyle MAC, Gorman G, Lynch C, O'Toole O, Jakeman P. Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis Growth Hormone and Igf Research. 17: 472-479. PMID 17697791 DOI: 10.1016/j.ghir.2007.06.002  0.48
2007 Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group Amyotrophic Lateral Sclerosis. 8: 195-213. PMID 17653917 DOI: 10.1080/17482960701262376  0.48
2007 Meldrum D, Cahalane E, Conroy R, Guthrie R, Hardiman O. Quantitative assessment of motor fatigue: Normative values and comparison with prior-polio patients Amyotrophic Lateral Sclerosis. 8: 170-176. PMID 17538779 DOI: 10.1080/17482960701223113  0.48
2007 Foley G, O'Mahony P, Hardiman O. Perceptions of quality of life in people with ALS: Effects of coping and health care Amyotrophic Lateral Sclerosis. 8: 164-169. PMID 17538778 DOI: 10.1080/17482960601164532  0.48
2007 Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 68: 1002-7. PMID 17389304 DOI: 10.1212/01.wnl.0000258551.96893.6f  0.48
2007 Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, ... ... Hardiman O, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 754-6. PMID 17371905 DOI: 10.1136/jnnp.2006.109553  0.48
2007 Meldrum D, Cahalane E, Conroy R, Fitzgerald D, Hardiman O. Maximum voluntary isometric contraction: Reference values and clinical application Amyotrophic Lateral Sclerosis. 8: 47-55. PMID 17364436 DOI: 10.1080/17482960601012491  0.48
2007 Hardiman O, Greenway M. The complex genetics of amyotrophic lateral sclerosis Lancet Neurology. 6: 291-292. PMID 17362828 DOI: 10.1016/S1474-4422(07)70062-5  0.48
2007 Ryan AM, Ryan J, Wan-Ahmed M, Hardiman O, Farrell MA, McNamara B, Sweeney BJ. Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 98-9. PMID 17172572 DOI: 10.1136/jnnp.2005.077982  0.48
2007 Hardiman O, Cronin S, Traynor BJ. Reply from the authors [8] Neurology. 69: 711-712. DOI: 10.1212/01.wnl.0000285431.01005.67  0.48
2006 O'Sullivan SS, Hardiman O. Detection rates of sexual dysfunction amongst patients with multiple sclerosis in an outpatient setting--can this be improved? Irish Medical Journal. 100: 304-306. PMID 17274174  0.48
2006 Momeni P, Schymick J, Jain S, Cookson MR, Cairns NJ, Greggio E, Greenway MJ, Berger S, Pickering-Brown S, Chiò A, Fung HC, Holtzman DM, Huey ED, Wassermann EM, Adamson J, ... ... Hardiman O, et al. Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. Bmc Neurology. 6: 44. PMID 17166276 DOI: 10.1186/1471-2377-6-44  0.48
2006 Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JHM, Hardiman O. Elevated serum angiogenin levels in ALS Neurology. 67: 1833-1836. PMID 17130418 DOI: 10.1212/01.wnl.0000244466.46020.47  0.48
2006 Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ. The epidemiology of ALS and the role of population-based registries. Biochimica Et Biophysica Acta. 1762: 1150-7. PMID 17071060 DOI: 10.1016/j.bbadis.2006.09.008  0.48
2006 Ryan A, Mullins G, Scott J, Connolly S, Hardiman O, Yilmaz E, Vincent A, Lynch T. A 45-year history of acquired autoimmune neuromyotonia. Journal of Neurology. 253: 1243-5. PMID 16998651 DOI: 10.1007/s00415-006-0172-5  0.48
2006 Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 67: 1074-7. PMID 16807408 DOI: 10.1212/01.wnl.0000231510.89311.8b  0.48
2006 Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH, Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nature Genetics. 38: 411-3. PMID 16501576 DOI: 10.1038/ng1742  0.48
2006 O'Sullivan PJ, Gorman GM, Hardiman OM, Farrell MJ, Logan PM. Sonographically guided percutaneous muscle biopsy in diagnosis of neuromuscular disease: a useful alternative to open surgical biopsy. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 25: 1-6. PMID 16371549  0.48
2006 O'Sullivan SS, Hardiman O. Detection rates of sexual dysfunction amongst patients with multiple sclerosis in an outpatient setting can this be improved? Irish Medical Journal. 99.  0.48
2005 Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. EFNS task force on management of amyotrophic lateral sclerosis: Guidelines for diagnosing and clinical care of patients and relatives: An evidence-based review with good practice points European Journal of Neurology. 12: 921-938. PMID 16324086 DOI: 10.1111/j.1468-1331.2005.01351.x  0.48
2005 Goodall EF, Greenway MJ, Van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS Neurology. 65: 934-937. PMID 16186539 DOI: 10.1212/01.wnl.0000176032.94434.d4  0.48
2005 Cahill CM, Hardiman O, Murphy KC. Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series. Cephalalgia : An International Journal of Headache. 25: 822-6. PMID 16162260 DOI: 10.1111/j.1468-2982.2005.00947.x  0.48
2005 Zaldívar T, Montejo Y, Acevedo AM, Guerra R, Vargas J, Garofalo N, Alvarez R, Alvarez MA, Hardiman O. Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population Neurology. 65: 636-638. PMID 16116135 DOI: 10.1212/01.wnl.0000172860.41953.12  0.48
2005 Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine. 171: 269-74. PMID 15516537 DOI: 10.1164/rccm.200403-314OC  0.48
2004 Hardiman O, Hickey A, O'Donerty LJ. Physical decline and quality of life in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5: 230-234. PMID 15799552 DOI: 10.1080/14660820410021294  0.48
2004 Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O. A novel candidate region for ALS on chromosome 14q11.2. Neurology. 63: 1936-8. PMID 15557516  0.48
2004 Kidney D, Alexander M, Corr B, O'Toole O, Hardiman O. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: Neurological and dysphagia specific rating scales Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5: 150-153. PMID 15512903 DOI: 10.1080/14660820410019675  0.48
2004 Meldrum D, Pittock SJ, Hardiman O, Ni Dhuill C, O'Regan M, Moroney JT. Recovery of the upper limb post ischaemic stroke and the predictive value of the Orpington Prognostic Score Clinical Rehabilitation. 18: 694-702. PMID 15473121 DOI: 10.1191/0269215504cr753oa  0.48
2004 Hutchinson M, Galvin R, Sweeney B, Lynch T, Murphy R, Redmond J, Traynor BJ, Hardiman O. Effect of a multidisciplinary clinic on survival in amyotrophic lateral sclerosis [2] (multiple letters) Journal of Neurology, Neurosurgery and Psychiatry. 75: 1208-1209. PMID 15258242 DOI: 10.1136/jnnp.2003.033076  0.48
2004 Sattin JA, Login IS, Cassidy EM, Hardiman O, Dinan T, O'Keane V. Buspirone challenge is not a valid probe of central 5-HT1A receptor function (multiple letters) Cephalalgia. 24: 510-512. PMID 15154863 DOI: 10.1111/j.1468-2982.2004.715_1.x  0.48
2004 O'Doherty LJ, Mickey A, Hardiman O. Quality of life in neurological illness: Generic versus individualised indicators Psychology and Health. 19: 124.  0.48
2003 Siddiqui K, Cahalane E, Keogan M, Hardiman O. Chronic ataxic neuropathy with cold agglutinins: Atypical phenotype and response to anti-CD20 antibodies Neurology. 61: 1307-1308. PMID 14610153  0.48
2003 Hardiman O, Corr B, Frost E, Gibbons P, Mahon L, Traynor BJ. Access to health services in Ireland for people with Multiple Sclerosis and Motor Neurone Disease. Irish Medical Journal. 96: 200-3. PMID 14518581  0.48
2003 Norquist JM, Jenkinson C, Fitzpatrick R, Swash M, Aarli JA, Burgunder JM, Evangelista T, Genthon R, Hardiman O, Illa I, Leigh PN, Ludin HP, Mazzini L, Meininger V, Mora JS, et al. Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 4: 112-117. PMID 14506943 DOI: 10.1080/14660820301190  0.48
2003 Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1258-61. PMID 12933930 DOI: 10.1136/jnnp.74.9.1258  0.48
2003 Pittock SJ, Meldrum D, Hardiman O, Deane C, Dunne P, Hussey A, Gorman M, Moroney JT. Patient and hospital delays in acute ischaemic stroke in a Dublin teaching hospital. Irish Medical Journal. 96: 167-8, 170-1. PMID 12926756  0.48
2003 Browne L, Hardiman O, O'Dwyer H, Farrell M. Intracranial giant cell arteritis with fatal middle cerebral artery territory infarct Clinical Neuropathology. 22: 199-203. PMID 12908757  0.48
2003 Ryan A, Nor AM, Costigan D, Foley-Nolan D, El-Rafie A, Farrell MA, Hardiman O. Polymyositis masquerading as motor neuron disease. Archives of Neurology. 60: 1001-3. PMID 12873858 DOI: 10.1001/archneur.60.7.1001  0.48
2003 Cassidy EM, Tomkins E, Hardiman O, O'Keane V. Factors associated with burden of primary headache in a specialty clinic Headache. 43: 638-644. PMID 12786924 DOI: 10.1046/j.1526-4610.2003.03106.x  0.48
2003 Meldrum D, Cahalane E, Keogan F, Hardiman O. Maximum voluntary isometric contraction: Investigation of reliability and learning effect Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 4: 36-44. PMID 12745617 DOI: 10.1080/14660820301176  0.48
2003 Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. Journal of Neurology. 250: 473-9. PMID 12700914 DOI: 10.1007/s00415-003-1026-z  0.48
2003 Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kaňovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, et al. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport®) in the treatment of spastic equinovarus deformity after stroke Cerebrovascular Diseases. 15: 289-300. PMID 12686794 DOI: 10.1159/000069495  0.48
2003 Galvin CD, Hardiman O, Nolan CM. IGF-1 receptor mediates differentiation of primary cultures of mouse skeletal myoblasts Molecular and Cellular Endocrinology. 200: 19-29. PMID 12644296 DOI: 10.1016/S0303-7207(02)00420-3  0.48
2003 Cassidy EM, Tomkins E, Sharifi N, Dinan T, Hardiman O, O'Keane V. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Pain. 101: 283-90. PMID 12583871 DOI: 10.1016/S0304-3959(02)00335-4  0.48
2003 Pittock SJ, Meldrum D, Dhuill CN, Hardiman O, Moroney JT. The Orpington Prognostic Scale Within the First 48 Hours of Admission as a Predictor of Outcome in Ischemic Stroke Journal of Stroke and Cerebrovascular Diseases. 12: 175-181. DOI: 10.1016/S1052-3057(03)00078-8  0.48
Show low-probability matches.